Free Trial

Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Price Passes Below 200 Day Moving Average - What's Next?

Northwest Biotherapeutics logo with Medical background

Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO - Get Free Report) shares passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.37 and traded as low as $0.26. Northwest Biotherapeutics shares last traded at $0.30, with a volume of 4,037,524 shares changing hands.

Northwest Biotherapeutics Stock Performance

The stock has a market cap of $395.24 million, a price-to-earnings ratio of -3.81 and a beta of -0.55. The business has a 50-day simple moving average of $0.30 and a two-hundred day simple moving average of $0.37.

Northwest Biotherapeutics (OTCMKTS:NWBO - Get Free Report) last issued its quarterly earnings results on Friday, August 9th. The biotechnology company reported ($0.02) EPS for the quarter. The business had revenue of $0.51 million for the quarter.

Northwest Biotherapeutics Company Profile

(Get Free Report)

Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer.

Further Reading

Should you invest $1,000 in Northwest Biotherapeutics right now?

Before you consider Northwest Biotherapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Northwest Biotherapeutics wasn't on the list.

While Northwest Biotherapeutics currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors
Nintendo Stock: Buy Before the 2025 Switch Platform Hits!
How to Profit from NVIDIA’s Earnings: Short-Term Trading Guide

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines